Biosimilars for psoriasis: clinical studies to determine similarity
Biosimilars are drugs that are similar, but not identical, to originator biologics. Pre-clinical analytical studies are required to show similarity on a molecular and structural level, but efficacy and safety studies in humans are essential to ultimately determine biosimilarity. In this review writt...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , |
|---|---|
| Formaat: | Revisão |
| Taal: | Engels |
| Gepubliceerd in: |
2016
|
| Online toegang: | https://doi.org/10.1111/bjd.15067 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|